PAUL A FRIEDMAN Insider Trading
Get free email notifications about insider trading for PAUL A FRIEDMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is an Chief Executive Officer in INCYTE CORP ($INCY) and a Director in INCYTE CORP ($INCY) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and an Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and a Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and a Director in Cerulean Pharma Inc. ($CERU) and a Director in Verastem, Inc. ($VSTM) and a Director in Prelude Therapeutics Inc ($PRLD).
Address: 3160 PORTER DRIVE PALO ALTO 94304 CA
Companies in which PAUL A FRIEDMAN is an Insider
ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 10,345 shares
Current Value: $1,321,263
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dare Bioscience, Inc.
Trading Symbol: DAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 18,819 shares
Current Value: $21,830
Latest Transaction: Apr 05 2017
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of PAUL A FRIEDMAN: Director, Chief Executive Officer
Holdings: 256,813 shares
Current Value: $30,350,160
Latest Transaction: May 28 2020
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MADRIGAL PHARMACEUTICALS, INC.
Trading Symbol: SNTAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Chief Executive Officer, Director
Holdings: 161,128 shares
Latest Transaction: Feb 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prelude Therapeutics Inc
Trading Symbol: PRLDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 347,522 shares
Latest Transaction: Jun 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verastem, Inc.
Trading Symbol: VSTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2016
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PAUL A FRIEDMAN
Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 31.02 | 23,344 | 724,131 | 23,344 | |
Feb 23 2021 | SNTA | MADRIGAL PHARMACEU ... | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 119.49 | 50,000 | 5,974,500 | 50,000 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 152,576 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | C | 0.00 | 295,794 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Option Exercise | P | 0.00 | 76,288 | 0 | 152,576 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 152,576 | 0 | 500,098 | 347.5 K to 500.1 K (+43.90 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | FRIEDMAN PAUL A | Director | Buy | C | 0.00 | 295,794 | 0 | 347,522 | 51.7 K to 347.5 K (+571.83 %) |